Skip to content
Screener

BioMarin Pharmaceuticals BMRN OCI Cash Flow Hedge Reclassification, Before Tax

OCI Cash Flow Hedge Reclassification, Before Tax at other companies

Accenture logo
AccentureACN
-$58.13M-3,077%
Medline, Inc. logo
Medline, Inc.MDLN
$10M-54.5%
International Business Machines logo
International Business MachinesIBM
-$342M-206%
PNC Financial Services logo
PNC Financial ServicesPNC
-$332M-140%
Accenture logo
AccentureACN
-$181.45M-59.7%
Medline, Inc. logo
Medline, Inc.MDLN
$7M+188%

Other financials

Income statement

See full
Revenue$989.7M+19.9%
Gross profit$786.9M+16.5%
Operating income$110.9M-59.9%
Net income$44.8M-81.4%
EPS (diluted)$0.23-81.3%

Balance sheet

See full
Cash & equivalents$874.0M-28.0%
Total debt$4.2B+598%
Total equity$6.3B+4.9%
Total assets$11.7B+57.2%

Cash flow

See full
Operating cash flow$168.1M-9.3%
CapEx$28.8M+68.5%
Free cash flow$139.3M-17.2%

Valuation

See full
Market cap$11.58B-0.6%
Enterprise value$14.89B+34.9%
P/E32.2×-34.7×
P/S3.4×-0.4×

Profitability

See full
Gross margin76.1%-3.4pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin21.7%-1.0pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.7×+0.6×
Current ratio2.4×-3.2×